loading

Finanzdaten der Braveheart Bio, Inc. Common Stock-Aktie (BRVE)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2026-06-30
Periodenlänge 3 Monate
Operating Expenses
Operating Income/Loss
Nonoperating Income/Loss
Net Income/Loss
Basic Average Shares
Diluted Average Shares
Basic Earnings Per Share
Diluted Earnings Per Share
$36.83
price down icon 0.41%
$38.37
price up icon 3.98%
$25.54
price down icon 0.51%
$12.08
price up icon 1.26%
$27.26
price up icon 3.89%
$24.63
price up icon 0.53%
Kapitalisierung:     |  Volumen (24h):